Back to top

EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT

Employee Secondment Agreement

EMPLOYMENT, CONFIDENTIAL INFORMATION,
INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT

You are currently viewing:
This Employee Secondment Agreement involves

SUPERGEN INC | Joseph Rubinfeld

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT
Governing Law: California     Date: 3/4/2004
Industry: BIOTRX     Sector: HEALTH

Search Employee Secondment Agreement by:

Document Title:

Entire Document: (optional)

50 of the Top 250 law firms use our Products every day
Exhibit 10

 

Exhibit 10.13

 

SUPERGEN, INC.

 

EMPLOYMENT, CONFIDENTIAL INFORMATION,
INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT

 

This Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (the “Agreement”) is entered into as of December 31, 2003 (the “Effective Date”), by and between SuperGen, Inc., a Delaware corporation (the “Company”), and Joseph Rubinfeld (“Employee”).

 

BACKGROUND

 

A.                                   The Company and Employee were parties to (i) that certain Employment, Confidential Information and Invention Assignment Agreement, dated as of January 1, 1994, as amended by Amendment No. 1 dated January 17, 1996, and as further amended and restated on January 1, 1998, (the “First Agreement”) and (ii) that certain Executive Employment, Confidential Information, Invention Assignment and Arbitration Agreement, dated March 1, 2002 (the “Second Agreement”), which superseded in its entirety the First Agreement (collectively, the “Prior Employment Agreements”).

 

B.                                     The Second Agreement will expire by its terms on December 31, 2003, and the parties desire to enter into this Agreement, which supersedes in its entirety the Prior Employment Agreements.

 

C.                                     Pursuant to the terms of the Second Agreement, which expires by its terms on December 31, 2003, Employee serves as the Company’s President and Chief Executive Officer.

 

NOW THEREFORE, in consideration of the respective covenants and agreements of the parties contained in this Agreement, the Company and Employee agree as follows:

 

AGREEMENT

 

1.                                       TERM.  The Company hereby agrees to employ Employee, and Employee hereby accepts employment, on the terms and conditions set forth herein.  The term of this Agreement shall commence upon the Effective Date and shall continue until and including December 31, 2004, unless otherwise terminated sooner by the parties (the “Term”).  The parties may agree to enter into another at-will employment agreement, on terms agreeable to both parties, at the end of the Term; provided, however, that Employee’s annualized base salary pursuant to such agreement shall not be less than $595,000, less applicable withholdings.

 

2.                                       AT-WILL EMPLOYMENT.  Notwithstanding the foregoing in Section 1 above, the parties agree that Employee’s employment with the Company will be “at-will” employment and may

 

1



 

be terminated for any reason at any time with or without notice.  Employee understands and agrees that neither his job performance, commendations, bonuses or the like from the Company give rise to or in any way serve as the basis for modification, amendment or extension, by implication or otherwise, of his employment with the Company.

 

3.                                       POSITION AND DUTIES.  Effective at midnight, Pacific Standard Time, on December 31, 2003, the Parties agree to Employee’s reassignment to the position of Chief Scientist of the Company from that of President and Chief Executive Officer of the Company (the “Reassignment”).  As a result of the Reassignment, Employee shall no longer be employed by the Company as an officer, and Employee hereby expressly consents to such Reassignment and resigns as President and Chief Executive Officer of the Company effective as of midnight, Pacific Standard Time, on December 31, 2003.  Employee will render such business and professional services in the performance of his duties as Chief Scientist as the Company will reasonably assign to him.  During the Term, Employee agrees to be available to perform employment services at Employee’s home office for no more than twenty (20) hours per week (at the request of the Company), provided that Employee agrees to be periodically available at the Company’s Dublin facilities upon the reasonable request of the Company.

 

4.                                       BOARD MEMBERSHIP.  Notwithstanding the Reassignment, Employee shall continue to serve as a member on the Company’s board of directors (the “Board”) until the next regularly scheduled meeting of the Company’s stockholders.  The Company will use reasonable efforts to nominate him to reelection as a member of the Board at that regularly scheduled meeting of stockholders and will use reasonable efforts to effect such reelection.  Employee shall serve on the Board as Chair Emeritus, with full membership and under the same terms and conditions to which all directors are subject.

 

5.                                       CONFIDENTIAL INFORMATION.

 

(a)                                  COMPANY INFORMATION.  Employee agrees at all times during the Term and thereafter, to hold in strictest confidence, and not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Confidential Information of the Company, except under a non-disclosure agreement duly authorized and executed by the Company.  Employee understands that “Confidential Information” means any non-public information that relates to the actual or anticipated business or research and development of the Company, technical data, trade secrets or know-how, including, but not limited to, research, product plans or other information regarding Company’s products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on whom Employee called or with whom Employee became acquainted during his entire term of his employment with the Company), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business information.  Employee further understands that Confidential Information does not include any of the foregoing items, which have become publicly known and made generally available through no wrongful act of Employee’s or of others who were under confidentiality obligations as to the item or items involved or improvements or new versions thereof.  The parties agree that disclosures of Confidential Information may be made by Employee, and that this paragraph shall not apply, (i) to the extent

 

2



 

necessary to comply with governmental disclosure requirements or applicable laws, (ii) pursuant to subpoena or order of any judicial, legislative, executive, regulatory or administrative body, or for Employee to lawfully enforce Employee’s rights under this Agreement and (iii) to employees, advisors, legal counsel and financial advisors as may be necessary and appropriate in connection with the proper performance and enforcement of this Agreement.

 

(b)                                 FORMER EMPLOYER INFORMATION.  Employee agrees that he will not, during his employment with the Company, improperly use or disclose any proprietary information or trade secrets of any former employer or other person or entity and that he will not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity.

 

(c)                                  THIRD PARTY INFORMATION.  Employee recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain limited purposes.  Employee agrees to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out Employee’s work for the Company consistent with the Company’s agreement with such third party.

 

6.                                       INVENTIONS.

 

(a)                                  INVENTIONS RETAINED AND LICENSED.  Employee has no inventions, original works of authorship, developments, improvements, and trade secrets which were made by him prior to his employment with the Company (collectively referred to as “Prior Inventions”), which belong to him, which relate to the Company’s proposed business, products or research and development, and which were not previously assigned to the Company.  If in the course of Employee’s employment with the Company, Employee incorporates into a Company product, process or service Prior Inventions owned by Employee or in which Employee has an interest, Employee hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Inventions as part of or in connection with such product, process or service, and to practice any methods related thereto.

 

(b)                                 ASSIGNMENT OF INVENTIONS.  Employee agrees that he will promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby assigns to the Company, or its designee, all of Employee’s right, title, and interest in and to any and all inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registrable under copyright or similar laws, which Employee may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, as a result of and within the scope of his duties as an Employee of the Company and during the period of time Employee is in the employ of the Company (collectively referred to as “Company Inventions”), except as provided in Section 6(f) below.  Employee further acknowledges that all original works of authorship which are made by him (solely or jointly with others) within the scope of and during the period of his employment with the Company, and which are protectable by

 

3



 

copyright, are “works made for hire,” as that term is defined in the United States Copyright Act.  Employee understands and agrees that the decision whether or not to commercialize or market any Company Inventions developed by Employee solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty will be due to Employee as a result of the Company’s efforts to commercialize or market any such Inventions.  The parties agree that any and all inventions, original works of authorship, development, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether or not patentable or registrable under copyright or similar laws which are made by Employee (solely or jointly with others) that are not within the scope of his duties for the Company (i.e., not during the time that he is actually performing duties for the Company) (collectively referred to as “non-Company Inventions”) shall not be subject to this paragraph and shall be the sole property of Employee and that he shall have the sole right, title and interest in any such non-Company Inventions.

 

(c)                                  INVENTIONS ASSIGNED TO THE UNITED STATES.  Employee agrees to assign to the United States government all his right, title, and interest in and to any and all Company Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its agencies.

 

(d)                                 MAINTENANCE OF RECORDS.  Employee agrees to keep and maintain adequate and current written records of all Inventions made by Employee (solely or jointly with others) during the period of his employment with the Company.  The records will be in the form of dated notes, sketches, drawings, and any other format that may be specified by the Company.  The records will be available to and remain the sole property of the Company at all times.

 

(e)                                  PATENT AND COPYRIGHT REGISTRATIONS.  Employee agrees to cooperate and assist the Company, or its designee, agents, and representatives, at the Company’s expense, in every proper way to secure and perfect the Company’s rights, title and interest in the Company Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the preparation and execution of all applications, patent applications, specifications, oaths, assignments, statements, declarations, petitions, certificates and petitions for correction and all other instruments which the Company or any government agency shall deem necessary in order to apply for, prosecute, correct and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Company Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries.  Employee further agrees that his obligation to execute or cause to be executed, when it is in his power to do so, any such instrument or papers shall continue after the termination of this Agreement without further consideration.  In addition, Employee covenants and agrees to take no action that would impair or interfere with the Company’s quiet enjoyment of its sole and exclusive rights, title and interest in and to such Company Inventions after termination of this Agreement.  If the Company is unable because of Employee’s mental or physical incapacity or for any other reason to secure Employee’s signature to apply for or to pursue, prosecute or correct any application for any United States or foreign patents or copyright registrations covering Company Inventions or original works of authorship assigned to the Company as above, then Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as his agent and attorney in fact, to

 

4



 

act for and in Employee’s behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution, correction, maintenance and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by Employee.

 

(f)                                    EXCEPTION TO ASSIGNMENTS.  Employee understands that the provisions of this Agreement requiring assignment of Company Inventions to the Company do not apply to any invention which qualifies fully under the provisions of California Labor Code Section 2870 (attached hereto as Exhibit A) or to any non-Company Inventions.  Employee will advise the Company in writing, within thirty (30) days, of any inventions that Employee believes meet the criteria in California Labor Code Section 2870.

 

7.                                       COMPENSATION, BONUS AND FRINGE BENEFITS.

 

(a)                                  BASE SALARY.  During the Term, the Company will pay Employee as compensation for his services a base salary at the annualized rate of Five Hundred and Ninety Five Thousand Dollars ($595,000), less applicable withholdings (the “Base Salary”).  The Base Salary shall be paid in periodic installments in accordance with the Company’s regular payroll practices.

 

(b)                                 DISCRETIONARY BONUS.  Employee shall be entitled to a discretionary bonus payment for 2003 in the amount of Two Hundred and Fifty Thousand Dollars ($250,000), less applicable withholdings (the “Bonus”). The Company shall pay Employee the Bonus within ten (10) business days after Employee executes (and does not revoke) the Release (as defined below), and the Release becomes effective (the “Release Date”).

 

(c)                                  OTHER BENEFITS.  Employee shall be entitled to participate in such group life, pension, disability, accident, hospital and medical insurance plans, and such other plan or plans which may be instituted by the Company for the benefit of its employees generally, upon such terms as may be therein provided of general application to all employees of the Company and such other benefits as are mutually deemed appropriate to the position held by Employee and to the discharge of Employee’s duties.  Employee shall be entitled to not less than twenty (20) business days’ vacation per year, with remuneration.

 

(d)                                 LIFE INSURANCE.  During the Term, the Company, at its expense, will maintain life insurance on behalf of Employee equal to one hundred and fifty percent (150%) of the Base Salary.  Employee will be entitled to select personal beneficiaries for 100% of the proceeds of the insurance policy.  The Company will provide Employee with additional cash compensation at the end of each calendar year to fully offset taxes attributable to Employee as a result of payment of the life insurance premiums by the Company.

 

8.                                       EXPENSES.  The Company will reimburse Employee, in accordance with the Company’s established policies, for reasonable business related expenses incurred by Employee in furtherance of or in connection with the performance of Employee’s duties hereunder, including reasonable expenses incurred in connection with Employee’s home office (including but not limited to a computer, telephone, fax and internet charges).  Employee shall furnish the Company with

 

5



 

evidence of such expenses within a reasonable period of time from the date such expenses were incurred.

 

9.                                       TERMINATION BENEFITS.

 

(a)                                  INVOLUNTARILY TERMINATION.  If, during the Term, the Company terminates Employee’s employment with the Company other than for Cause (as defined herein), death or Disability (as defined herein), and Employee signs and does not revoke a standard release of claims with the Company, then Employee will be entitled to receive continuing payments of severance pay (less applicable withholding taxes) at a rate equal to his Base Salary rate, as then in effect, until December 31, 2004  (the “Payment”).  The Payment will be paid in accordance with the Company’s normal payroll practices.

 

(b)                                 VOLUNTARY TERMINATION.  In the event the Employee voluntarily terminates his employment with the Company for any reason (except as otherwise provided for herein) during the Term, and Employee signs and does not revoke a standard release of claims with the Company, then Employee will be entitled to receive continuing payments (less applicable withholding taxes) at a rate equal to 50% of his Base Salary rate, as then in effect, until December 31, 2004 (the “Continuing Payment”). The Continuing Payment will be paid in accordance with the Company’s normal payroll practices.

 

(c)                                  TERMINATION FOR CAUSE, DEATH OR DISABILITY.  In the event Employee’s employment with the Company is terminated for Cause, death or Disability, then Employee shall not be entitled to receive the Payment or the Continuing Payment, but may be eligible for those benefits (if any) as may then be established under the Company’s then existing severance policies at the time of such termination.

 

(d)                                 ACCRUED WAGES AND VACATION; EXPENSES.  Without regard to the reason for, or the timing of, Employee’s termination of employment:  (i) the Company shall pay Employee any unpaid base salary due for periods prior to his termination of employment; (ii) the Company shall pay Employee all of Employee’s accrued and unused vacation through his termination of employment; and (iii) following submission of proper expense reports by the Employee, the Company shall reimburse Employee for all expenses reasonably and necessarily incurred by Employee in connection with the business of the Company prior to his termination of employment.  These payments shall be made promptly upon Employee’s termination of employment and within the period of time mandated by law.

 

(e)                                  CAUSE.  For the purposes of this Agreement, “Cause” means (i) any act of personal dishonesty taken by Employee in connection with his responsibilities which is intended to result in personal enrichment of Employee, (ii) Employee’s conviction of a felony, (iii) any act by Employee that constitutes material misconduct and is injurious to the Company, or (iv) continued violations by Employee of his obligations to the Company; provided that, in each case except (ii), Employee has received written notice of the described activity, has been afforded a reasonable opportunity to cure or correct the activity (not to exceed 15 days) as described in the notice, and has failed to cure, correct or cease the activity, as appropriate.

 

6



 

(f)                                    DISABILITY.  For purposes of this Agreement, “Disability” shall mean a disability, due to illness or injury, which materially limits Employee from performing each of his material and substantial duties, even with reasonable accommodation, for a period of six (6) consecutive months.  The Company shall provide Employee fourteen (14) days’ written notice of termination for Disability.

 

10.                                 STOCK OPTIONS.

 

(a)                                  MILESTONE STOCK OPTIONS.  Employee has heretofore been granted by the Company options to purchase the Company’s common stock, which vest upon the attainment of certain milestones and triggers (the “Milestone Option”).  As of the date hereof, approximately 300,000 shares subject to the Milestone Option are unvested.  The Company shall accelerate, on or about the Release Date, the vesting of 170,000 shares subject to the Milestone Option, in tranches of 100,000 shares and 70,000 shares respectively, as identified by Employee.  The remaining 130,000 shares subject to the Milestone Option shall continue to vest in accordance with the terms of the stock option plan under which they were issued and the stock option agreement between the Company and Employee

 

(b)                                 OPTION ACCELERATION IN THE EVENT OF INVOLUNTARY TERMINATION FOLLOWING A CHANGE OF CONTROL.  If, during the Term, Employee’s employment with the Company or a successor corporation is terminated by the Company or successor corporation as a result of an Involuntary Termination (as defined below) following a Change of Control (as defined below), Employee shall be entitled to full acceleration of the vesting of any then unvested stock options (including all unvested Milestone Options) then held by Employee, and such accelerated options shall remain subject to and be exercisable in accordance with the terms of the stock option plan under which they were issued and the stock option agreement between the Company and Employee.

 

(c)                                  CHANGE OF CONTROL.  For purposes of this Agreement, “Change of Control” means the occurrence of any of the following events:  (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

 

(d)                                 INVOLUNTARY TERMINATION.  For purposes of this Agreement, “Involuntary Termination” means (i) without Employee’s express written consent, a significant reduction of Employee’s duties, position or responsibilities relative to Employee’s duties, position or responsibilities in effect immediately prior to such reduction; (ii) without Employee’s express

 

7



 

written consent, a substantial reduction, without good business reasons, of the facilities and perquisites (including office space and location) available to Employee immediately prior to such reduction; (iii) without Employee’s express written consent, a material reduction by the Company of Employee’s Base Salary as in effect immediately prior to such reduction; (iv) without Employee’s express written consent, a material reduction by the Company in the kind or level of employee benefits to which Employee is entitled immediately prior to such reduction with the result that Employee’s overall benefits package is significantly reduced; (v) without Employee’s express written consent, the relocation of Employee to a facility or a location more than fifty (50) miles from his current location, or (vi) any purported termination of Employee other than for Cause (as defined in this Agreement).

 

11.                                 RELEASE OF CLAIMS.  In consideration for the receipt of the Bonus provided for in Section 7(b) hereof, Employee agrees to execute and not revoke, in the form substantially attached hereto as Exhibit B, a mutual release of claims covering potential claims by both parties against the other up to and including the Effective Date (the “Release”).  In no event shall the Company be obligated to provide, and Employee shall have no right to receive, the Bonus in the event (i) Employee fails to execute the Release or (ii) Employee revokes the Release.  Furthermore, in consideration of the Termination Benefits provided for in Sections 9(a) and/or 9(b), Employee agrees to execute and not revoke, in a form substantially similar to Exhibit C, a mutual release of claims for the time period covering the Term (the “Second Release”).  The Company will also execute the Release and the Second Release once, and if, Employee executes each document.

 

12.                                 LIMITATION ON PAYMENTS.  In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Employee, including but not limited to, the accelerated vesting of any stock options previously or hereafter granted to Employee, (i) constitute “parachute payments” within the meaning of Section 280G of the Code, and (ii) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then Employee’s benefits under this Agreement shall be reduced to the extent necessary in order to avoid such benefits being subject to the Excise Tax.

 

Unless the Company and Employee otherwise agree in writing, any determination required under this Section 12 shall be made in writing by the Company’s independent public accountants (the “Accountants”), whose determination shall be conclusive and binding upon Employee and the Company for all purposes.  For purposes of making the calculations required by this Section 12, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Section 280G and 4999 of the Code.  The Company and Employee shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 12.  The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 12.

 

13.                                 NONSOLICITATION.  During the Term and for a period of twelve (12) months following Employee’s termination of employment with the Company for any reason, Employee agrees that he shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s employees to leave their employment, or attempt to solicit, induce, recruit, or encourage

 

8



 

any of the Company’s employees to leave their employment with the Company, either for himself or any other person or entity.

 

14.                                 NON-COOPERATION.  Employee agrees that he will not counsel or assist any stockholder of the Company, attorneys, their clients or any individual in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company and/or any officer, director, employee, agent, representative, stockholder or attorney of the Company, unless (a) under a subpoena or other court order to do so or (b) pursuant to a derivative action against the Company where Employee is in the plaintiff class.

 

15.                                 NON-DISPARAGEMENT.  Employee agrees to refrain from any defamation, libel or slander of the Company, any parent or subsidiary of the Company and/or any officer, director, employee, agent, representative, stockholder, successor, predecessor or affiliate thereof or to engage in any tortious interference with the contracts and relationships of the Company, any parent and/or subsidiary of the Company.  The Company, any parent or subsidiary of the Company and/or any officer, director, employee, agent, representative, stockholder, successor, predecessor or affiliate thereof agrees to refrain from any defamation, libel or slander of Employee.

 

16.                                 RIGHT OF FIRST REFUSAL.  Subject to the terms and conditions herein, Employee shall be free to seek other employment with third parties (each, an “Other Employer”); provided that during the Term the Company shall have a right of first refusal with respect to the development, registration and/or commercialization of all Anti-Cancer Compounds (as defined below) developed by Other Employers during the Term.  Employee shall ensure that its written employment agreements with Other Employers contain provisions expressly granting such right of first refusal to the Company as provided in this Section 16.  For purposes of the foregoing, “Anti-Cancer Compounds” shall mean pharmaceutical compounds for treatment, diagnosis, palliation, and/or prevention of cancer, including without limitation, hematology-oncology, immunology and related fields.

 

17.                                 SURVIVAL OF CERTAIN PROVISIONS.  For the avoidance of doubt, the parties expressly agree and understand that Sections 5, 6, 14 and 15 of this Agreement shall remain in full force and effect in perpetuity.

 

search for free browse for free learn more